Latest SEC Filings

Redwire CorpRedwire Corporation Reports 90% Revenue Growth to $117.1 Million in Latest Quarter

Organogenesis Holdings Inc.Organogenesis Holdings Reports 57% Revenue Decline and $99.3 Million Net Loss

ROKU, INCRoku Reports 22% Revenue Growth to $1.35 Billion, Announces Merger with Fox Corporation

Liberty Live Holdings, Inc.Liberty Live Holdings Reports Q2 2026 Revenue Growth but Wider Net Loss

INNODATA INCInnodata Reports 58% Revenue Growth to $92.1 Million in Q2 2026

RELMADA THERAPEUTICS, INC.Relmada Therapeutics Reports $31.97 Million Net Loss and Significant Asset Growth in Latest 10-Q

TaskUs, Inc.TaskUs Reports 5% Revenue Growth to $308.9 Million in Q2 2026

CNO Financial Group, Inc.CNO Financial Group Reports Significant Increase in Q2 2026 Net Income to $125.9 Million

Hinge Health, Inc.Hinge Health Reports 53% Revenue Growth to $212.8 Million in Latest Quarter

BIOMARIN PHARMACEUTICAL INCBioMarin Reports 20% Revenue Growth to $989.7 Million in Q2 2026

POWER SOLUTIONS INTERNATIONAL, INC.Power Solutions International Reports 21% Decline in Q2 2026 Net Sales

US Foods Holding Corp.US Foods Reports Revenue Growth and Improved Operating Income for 13 and 26 Weeks Ended June 27, 2026

AH Realty Trust, Inc.AH Realty Trust Reports $24.2 Million Net Loss in Q2 2026, Revenue Increases to $52.5 Million

Shift4 Payments, Inc.Shift4 Payments Reports 34% Revenue Growth to $1.295 Billion in Latest Quarter

Roman DBDR Acquisition Corp. IIRoman DBDR Acquisition Corp. II Reports Q2 2026 Financial Results and Business Combination Plans

LIFETIME BRANDS, INCLifetime Brands Reports 7.4% Revenue Growth in Q2 2026, Highlights Strategic Developments

PELOTON INTERACTIVE, INC.Peloton Reports $2.446 Billion Revenue for Fiscal Year 2026, Net Income Recovery Achieved

GILEAD SCIENCES, INC.Gilead Sciences Reports $10.5 Billion Net Loss Despite 10% Revenue Growth in Q2 2026

Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals Reports $42.3 Million Net Loss in Q2 2026

Phio Pharmaceuticals Corp.Phio Pharmaceuticals Reports $4.1 Million Net Loss in Q2 2026, Focuses on Clinical Development of PH-762

Artiva Biotherapeutics, Inc.Artiva Biotherapeutics Reports $25M Net Loss and $368.6M in Assets for Q2 2026

TheRealReal, Inc.The RealReal Reports 16.6% Revenue Growth to $192.6 Million in Q2 2026

Driven Brands Holdings Inc.Driven Brands Reports 7% Revenue Growth to $507.4 Million in Q2 2026

BENTLEY SYSTEMS INCBentley Systems Reports 12.8% Revenue Growth to $410.7 Million in Q2 2026

Verastem, Inc.Verastem Reports $40.1 Million Revenue in Q2 2026, Despite $34.7 Million Net Loss